BioWorld - Thursday, January 29, 2026

BioWorld Science

May 7, 2018

View Archived Issues

MenoGeniX receives grant from NIA for drug to treat menopausal hot flashes

Read More

FDA grants fast track designation for PaxVax's chikungunya VLP vaccine

Read More

GAL-200-10 controls corneal neovascularization and fibrosis in vivo

Read More

DSMB gives another recommendation for phase III FOCUS trial

Read More

Astellas reports pipeline highlights of fourth quarter of fiscal 2017

Read More

Novel oral antibiotic DDS-01 presented for treating multidrug-resistant gonorrhoea infections

Read More

Cancer therapy driven by dopamine D2 receptor antagonism shows promise

Read More

Merck & Co. patents novel LXR-beta agonists

Read More

FDA approves Tafinlar with Mekinist for BRAF-positive anaplastic thyroid cancer

Read More

Isofol receives FDA feedback on SPA for pivotal study of arfolitixorin in colorectal cancer

Read More

Sage Therapeutics identifies GluN2A and/or GluN2B NAMs

Read More

Evolve doses first pediatric patient in phase III trial of PlasmaCap IG

Read More

FDA grants priority review to Tecentriq sBLA for first-line treatment of metastatic NSCLC

Read More

Lilly initiates phase III study of mirikizumab in moderate to severe plaque psoriasis

Read More

monARC Bionetworks begins strategic integration with Roivant drug development platform

Read More

Novel ELOVL4 gene mutation tied to spinocerebellar ataxia with retinitis pigmentosa

Read More

Charles River Laboratories extends collaboration with Michael J. Fox Foundation

Read More

ORR data from KEYNOTE-407 trial of Keytruda in first-line NSCLC support sBLA submission

Read More

New mutation in SLC20A2 gene found in Fahr's disease

Read More

FDA approves IND for female hair loss trial of Histogen's HSC-660

Read More